An emerging challenge for COVID-19 researchers is increasing sequencing throughput for all plasmid and viral samples that are collected for drug discovery, genomic epidemiology, and surveillance. Scientists require fast access to high-quality research tools and data, which includes access to large-scale collections and scalable sequencing workflows. seqWell’s NGS library prep technology accelerates sequencing of large sample collections and is being applied to high-throughput SARS-CoV-2 surveillance, diagnostic, and research workflows.
Join Addgene and seqWell for a discussion of how plexWell sequencing technology has enabled log-scale increases in sequencing throughput for important COVID-19 applications.
COVID-19 case studies include:
Joseph Mellor PhD
Joseph Mellor, PhD is CEO at seqWell, a Beverly, Massachusetts based genomics solutions company started in 2014. With a background in computational biology and genomic technology development, Joe previously held research positions at Harvard Medical School and the University of Toronto.
You can find Joe on LinkedIn.
Joanne Kamens PhD
Joanne Kamens, Ph.D. is the Executive Director of Addgene, a mission driven, nonprofit dedicated to helping scientists around the world share useful research reagents and data.
She serves on a number of other nonprofit boards including as Vice Chair of the Seeding Labs BoD and advisor to the Scismic job board for scientists and speaks widely on career development, mentoring and workplace diversity topics in person and via webinar.